3760 Rocky Mountain Avenue
United States - Map
Heska Corporation develops, manufactures, markets, sells, and supports veterinary products for canine and feline companion animal health markets in the United States and internationally. The company offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HEMATRUE veterinary hematology analyzer to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; VitalPath blood gas and electrolyte analyzer to measure blood gases, electrolytes, hematocrit, and other parameters; and IV pumps, as well as services and supports HESKA CBC-DIFF veterinary hematology system. It also provides point-of-care diagnostic test products comprising heartworm diagnostic products for dogs and cats; veterinary diagnostic laboratory products and services, such as allergy diagnostic products and services; pharmaceuticals and supplements, including heartworm prevention and hypothyroid treatment products, and nutritional supplements; vaccines and other biologicals for allergy treatment and feline respiratory diseases; and veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products consumable supplies. In addition, the company offers bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. Heska Corporation sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors, as well as trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.
|Dr. Robert B. Grieve Ph.D.,
Co-Founder, Chairman and Chief Exec. Officer
|Mr. Jason A. Napolitano ,
Chief Financial Officer, Exec. VP and Sec.
|Dr. Nancy Wisnewski Ph.D.,
Exec. VP of Product Devel. and Customer Support
|Dr. Michael J. McGinley Ph.D.,
Pres of Biologicals & Pharmaceuticals
|Mr. Kevin S. Wilson ,
Pres and Chief Operating Officer
|Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|